WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Stock

$108.80+2.30 (+2.16%)
Updated Dec 7, 2023
ASND Price
$108.80
Fair Value Price
N/A
Market Cap
$6.27B
52 Week Low
$64.33
52 Week High
$127.77
P/E
-9.54x
P/B
-80.3x
P/S
32.61x
PEG
N/A
Dividend Yield
N/A
Revenue
$161.61M
Earnings
-$640.41M
Gross Margin
80.2%
Operating Margin
-346.47%
Profit Margin
-396.3%
Debt to Equity
-12.89
Operating Cash Flow
-$603M
Beta
0.71
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ASND Overview

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ASND scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ASND is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASND is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ASND's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ASND due diligence checks available for Premium users.

Be the first to know about important ASND news, forecast changes, insider trades & much more!

ASND News

Valuation

ASND fair value

Fair Value of ASND stock based on Discounted Cash Flow (DCF)
Price
$108.80
Fair Value
$98.21
Overvalued by
10.78%
ASND is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ASND price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-9.54x
Industry
11.53x
Market
31.17x

ASND price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-80.3x
Industry
5.45x

ASND's financial health

Profit margin

Revenue
$51.1M
Net Income
-$172.6M
Profit Margin
-337.7%
ASND's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ASND's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$929.0M
Liabilities
$1.0B
Debt to equity
-12.89
ASND's short-term assets ($779.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASND's long-term liabilities ($780.73M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASND's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ASND's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$132.7M
Investing
$23.6M
Financing
$152.5M
ASND's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ASND vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ASND$6.27B+2.16%-9.54x-80.30x
BBIO$5.85B+3.70%-8.62x-4.84x
IMVT$5.83B+3.20%-20.55x23.13x
EXEL$6.84B+0.27%78.54x2.91x
CRSP$5.58B-1.31%-15.74x3.23x

Ascendis Pharma A Stock FAQ

What is Ascendis Pharma A's quote symbol?

(NASDAQ: ASND) Ascendis Pharma A trades on the NASDAQ under the ticker symbol ASND. Ascendis Pharma A stock quotes can also be displayed as NASDAQ: ASND.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

What is the 52 week high and low for Ascendis Pharma A (NASDAQ: ASND)?

(NASDAQ: ASND) Ascendis Pharma A's 52-week high was $127.77, and its 52-week low was $64.33. It is currently -14.85% from its 52-week high and 69.13% from its 52-week low.

How much is Ascendis Pharma A stock worth today?

(NASDAQ: ASND) Ascendis Pharma A currently has 57,656,568 outstanding shares. With Ascendis Pharma A stock trading at $108.80 per share, the total value of Ascendis Pharma A stock (market capitalization) is $6.27B.

Ascendis Pharma A stock was originally listed at a price of $18.83 in Jan 28, 2015. If you had invested in Ascendis Pharma A stock at $18.83, your return over the last 8 years would have been 477.8%, for an annualized return of 24.52% (not including any dividends or dividend reinvestments).

How much is Ascendis Pharma A's stock price per share?

(NASDAQ: ASND) Ascendis Pharma A stock price per share is $108.80 today (as of Dec 7, 2023).

What is Ascendis Pharma A's Market Cap?

(NASDAQ: ASND) Ascendis Pharma A's market cap is $6.27B, as of Dec 8, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ascendis Pharma A's market cap is calculated by multiplying ASND's current stock price of $108.80 by ASND's total outstanding shares of 57,656,568.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.